Cindy A.

Cindy A. has a diverse work experience in the medical field. Cindy is currently working at ReCor Medical as a Medical Affairs Manager focusing on hypertension. Prior to that, they were a Clinical Data Team Manager specializing in oncology at Mendel.ai. In this role, they managed customer deliveries and coordinated with clinical research teams. Cindy also managed a remote team of clinicians to perform high-quality abstraction and annotation for AI development. Before that, Cindy worked at InCarda Therapeutics as a Translational and Clinical Project Lead, where they conducted clinical strategy analysis and developed a workflow for remote patient monitoring. Cindy also has experience as a Medical History Specialist at MD Medical Group and as a General Physician at Clinica El Rocío.

Cindy A. has an extensive education history in the field of medicine and bioengineering. Cindy began their academic journey in 2010 at Urgemed, where they obtained a degree in Pre-Medicine/Pre-Medical Studies as a Medical Emergencies Technician. In 2011, they continued their studies at Instituto Politécnico Nacional and completed a degree in Medico Cirujano y Partero/Doctor of Medicine (MD), specializing in Medicine.

Cindy A. then pursued further education by joining the Medico Interno de Pregrado program at Hospital Escandón from 2016 to 2017. In 2020, they enrolled in multiple educational programs simultaneously. Cindy attended the University of California, Berkeley, where they earned a Master's degree in Translational Medicine and Bioengineering. At the same time, they pursued a Master of Translational Medicine at the University of California, San Francisco, with a focus on Biotechnology.

Additionally, in 2020, Cindy A. joined the Clinical Research Associate Program at Kriger Research Group International to further enhance their knowledge and skills in the field. Throughout their educational journey, Cindy A. also obtained several certifications including Essentials of Human Subjects Research, Group 1 Biomedical Research Investigators, and Conflicts of Interest from CITI Program, a division of BRANY, in October 2020.